Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Ishiguchi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Anti-Cancer Drugs|May 2, 2002
Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapyTakayuki Torigoe, Hiroto Izumi, Tomoko Ise, et al.
Cancer Treatment Reviews|October 31, 2003
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapyHiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, et al.
Frontiers in Neurology|November 8, 2023
Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis/encephalopathyShuhei Ogami, Jinsoo Koh, Katsuichi Miyamoto, et al.
The Journal of Biological Chemistry|July 23, 2002
Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agentsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Biochemical and Biophysical Research Communications|July 20, 2002
Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNAYoichiro Yoshida, Hiroto Izumi, Tomoko Ise, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Cisplatin resistance and transcription factorsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Scientific Reports|July 12, 2020
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson's diseaseJinsoo Koh, Yoshiki Kaneoke, Tomohiro Donishi, et al.
Journal of Human Genetics|June 27, 2022
Comparison of two families with and without ataxia harboring novel variants in PRKCGYui Tada, Kodai Kume, Soma Noguchi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Anti-Cancer Drugs|May 2, 2002
Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapyTakayuki Torigoe, Hiroto Izumi, Tomoko Ise, et al.
Cancer Treatment Reviews|October 31, 2003
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapyHiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, et al.
Frontiers in Neurology|November 8, 2023
Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis/encephalopathyShuhei Ogami, Jinsoo Koh, Katsuichi Miyamoto, et al.
The Journal of Biological Chemistry|July 23, 2002
Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agentsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Biochemical and Biophysical Research Communications|July 20, 2002
Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNAYoichiro Yoshida, Hiroto Izumi, Tomoko Ise, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Cisplatin resistance and transcription factorsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Scientific Reports|July 12, 2020
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson's diseaseJinsoo Koh, Yoshiki Kaneoke, Tomohiro Donishi, et al.
Journal of Human Genetics|June 27, 2022
Comparison of two families with and without ataxia harboring novel variants in PRKCGYui Tada, Kodai Kume, Soma Noguchi, et al.
Pageof 2